Pfizer Ends Drug Cards for Elderly
 
Current News and Headlines
(Updated 06/08/2005 )
    "CAFTA outlook clouded by NAFTA's failure for farmers"  
    "GM Plans to Cut 25,000 Jobs"      
   

"Medical errors still claiming many lives"

 
  Archive  
    View Previous "Jobs" Articles  
    View Previous "Healthcare" Articles  
    View Previous "Fair Trade " Articles  
  Latest Media  
    AEJ Press Release  
AEJ Iowa Ad
Windows Media Player
    AEJ HealthCare Ad  
               
 

By MILT FREUDENHEIM
 

 

PPhizer, the nation's largest drug maker, ended its widely used discount card for the elderly yesterday, leaving several hundred thousand low-income Medicare beneficiaries at least temporarily without access to reduced prices for popular medicines like the cholesterol treatment Lipitor.

The company said that it had been warning its 536,000 cardholders for months that it would discontinue the discount program on Aug. 31 and that it had advised them to sign up for various discount cards that became available under a new Medicare program that began in June.

But consumer advocates, citing the widespread confusion over the new Medicare program, had asked Pfizer to keep its discount card in place until 2006 - the year that prescription drugs will become a standard part of Medicare benefits.

"A lot of people will be left high and dry starting tomorrow," said Robert M. Hayes, president of the Medicare Rights Center, a nonprofit consumer advocacy group.

Under the former Pfizer card, a 30-day supply of Lipitor cost $15 - compared with $68 at one Internet pharmacy, for example, or $43.32 at one Canadian Web site

Read More

 
     
 
The New York Times On The Web 
 
     
 
©2004 Alliance For Economic Justice
| Members | About AEJ | Contact Us | Links |